Gardasil 9 — 9-Valent HPV Vaccine

Gardasil 9 is a conjugate vaccine intended to prevent diseases caused by Human Papillomavirus (HPV). The vaccine protects against 9 common HPV types including 6, 11, 16, 18, 31, 33, 45, 52, and 58, helping to reduce the risk of genital warts, condyloma acuminata, precancerous lesions, and related cancers such as cervical, vaginal, vulvar, anal, head-and-neck, and oropharyngeal cancers.

Ingredients & Dosage:

Each 0.5 mL contains recombinant L1 protein from 9 HPV types, with aluminum adjuvant.

Pharmaceutical form: injectable suspension, for intramuscular injection, supplied in pre-filled syringes or single-dose vials.

Target Audience & Dosing:

For individuals aged 9 to 45, both male and female.

Children 9–14 years old: 2 or 3 doses as recommended.

Individuals aged 15 and older: usually 3 doses.

Mechanism of Action:
The vaccine, a recombinant L1 capsid protein of HPV, stimulates the body to produce antibodies and cell-mediated immunity, helping to prevent HPV infection and virus-induced lesions.

Indications for Prevention:
Prevention of HPV infection, genital warts, precancerous lesions, condyloma acuminata, and related cancers such as cervical, vaginal, vulvar, anal, head-and-neck, and oropharyngeal.

Storage:
Store refrigerated at 2–8 °C, do not freeze, protect from direct light.